Publications

  1. Behrens M, Smart M, Luckey D, Luthra H, Taneja V. To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice. J Autoimmun. 2011 Sep; 37(2):95-103. Epub 2011 Jun 12. 2170007
    View PubMed
  2. Behrens M, Papadopoulos GK, Moustakas A, Smart M, Luthra H, David CS, Taneja V. Trans heterodimer between two non-arthritis-associated HLA alleles can predispose to arthritis in humanized mice. Arthritis Rheum. 2011 Jun; 63(6):1552-61. 2147351
    View PubMed
  3. Kermani TA, Crowson CS, Achenbach SJ, Luthra HS. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc. 2011 Apr; 86(4):297-303. 2155123
    View PubMed
  4. Akkara Veetil BM, Luthra H. Erdheim-Chester disease. Clin Rheumatol. 2011 Mar; 30(3):397-8. Epub 2010 Oct 15. 2121150
    View PubMed
  5. Behrens M, Trejo T, Luthra H, Griffiths M, David CS, Taneja V. Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice. J Autoimmun. 2010 Aug; 35(1):1-9. Epub 2010 Jan 12. 1980514
    View PubMed
  6. Kumar N, Sandroni P, Steensma DP, Luthra HS, Habermann TM. Polyradiculopathy due to methotrexate-induced ebv-associated lymphoproliferative disorder. Neurology. 2008 Nov 11; 71(20):1644-5. 1915387
    View PubMed
  7. Taneja V, Behrens M, Basal E, Sparks J, Griffiths MM, Luthra H, David CS. Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis. J Immunol. 2008 Aug 15; 181(4):2869-77. 1902514
    View PubMed
  8. Kermani TA, Luthra HS. Folate supplementation and methotrexate in treatment of rheumatoid arthritis. Indian Journal of Rheumatology. 2008; 3(2):77-9. 1978687
    View PubMed
  9. Chowdhary VR, Grande JP, Luthra HS, David CS. Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus. Rheumatology (Oxford). 2007 Sep; 46(9):1405-10. Epub 2007 Jun 18. 1844393
    View PubMed
  10. Taneja V, Krco CJ, Behrens MD, Luthra HS, Griffiths MM, David CS. B cells are important as antigen presenting cells for induction of MHC-restricted arthritis in transgenic mice. Mol Immunol. 2007 Apr; 44(11):2988-96. Epub 2007 Feb 14. 1827903
    View PubMed
  11. Taneja V, Behrens M, Mangalam A, Griffiths MM, Luthra HS, David CS. New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. Arthritis Rheum. 2007 Jan; 56(1):69-78. 2304847
    View PubMed
  12. Cauduro SA, Moder KG, Luthra HS, Seward JB. Echocardiographically guided pericardiocentesis for treatment of clinically significant pericardial effusion in rheumatoid arthritis. J Rheumatol. 2006 Nov; 33(11):2173-7. 1792870
    View PubMed
  13. Chowdhry V, Kumar N, Lachance DH, Salomao DR, Luthra HS. An unusual presentation of rheumatoid meningitis. J Neuroimaging. 2005 Jul; 15(3):286-8. 1720579
    View PubMed
  14. Taneja V, Taneja N, Behrens M, Griffiths MM, Luthra HS, David CS. Requirement for CD28 may not be absolute for collagen-induced arthritis: study with HLA-DQ8 transgenic mice. J Immunol. 2005 Jan 15; 174(2):1118-25. 1680778
    View PubMed
  15. Kent PD, Luthra HS, Michet CJ. Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis. J Rheumatol. 2004 Sep; 31(9):1727-31. 1665819
    View PubMed
  16. Kent PD, Michet CJ Jr, Luthra HS. Relapsing polychondritis. Curr Opin Rheumatol. 2004 Jan; 16(1):56-61. 1647213
    View PubMed
  17. Tripuraneni R, Houghton SG, Luthra HS, Grogg KL, vanHeerden JA. What can be done for a woman with ‘holes’ in her spleen? Contemporary Surgery. 2004; 60(9):418-22. 1678596
    View PubMed
  18. Siegel JL, Luthra H, Donlinger J, Angulo P, Lindor K. Association of primary biliary cirrhosis and rheumatoid arthritis. J Clin Rheumatol. 2003 Dec; 9(6):340-3. 1431613
    View PubMed
  19. Taneja V, Griffiths M, Behrens M, Luthra HS, David CS. Auricular chondritis in NOD.DQ8.Abetao (Ag7-/-) transgenic mice resembles human relapsing polychondritis. J Clin Invest. 2003 Dec; 112(12):1843-50. 1429391
    View PubMed
  20. Taneja V, Taneja N, Behrens M, Pan S, Trejo T, Griffiths M, Luthra H, David CS. HLA-DRB1*0402 (DW10) transgene protects collagen-induced arthritis-susceptible H2Aq and DRB1*0401 (DW4) transgenic mice from arthritis. J Immunol. 2003 Oct 15; 171(8):4431-8. 1985409
    View PubMed
  21. Klos K, Flemming KD, Petty GW, Luthra HS. Takayasu's arteritis with arteriographic evidence of intracranial vessel involvement. Neurology. 2003 May 13; 60(9):1550-1. 1346718
    View PubMed
  22. Moder KG, Gaffey TA, Luthra HS. A smoker with a pulmonary nodule and progressive neurologic deficits... Wegener granulomatosis, fortieth in a series. J Musculoskeletal Med. 2003 May; 20(5):251-3. 1652619
    View PubMed
  23. Bidaut-Russell M, Gabriel SE, Scott CG, Zinsmeister AR, Luthra HS, Yawn B. Determinants of patient satisfaction in chronic illness. Arthritis Rheum. 2002 Oct 15; 47(5):494-500. 1316730
    View PubMed
  24. Taneja V, Taneja N, Paisansinsup T, Behrens M, Griffiths M, Luthra H, David CS. CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J Immunol. 2002 Jun 1; 168(11):5867-75. 1315757
    View PubMed
  25. Paisansinsup T, Deshmukh US, Chowdhary VR, Luthra HS, Fu SM, David CS. HLA class II influences the immune response and antibody diversification to Ro60/Sjogren's syndrome-A: Heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules. J Immunol. 2002 Jun 1; 168(11):5876-84. 1315758
    View PubMed
  26. Paisansinsup T, Vallejo AN, Luthra H, David CS. HLA-DR modulates autoantibody repertoire, but not mortality, in a humanized mouse model of systemic lupus erythematosus. J Immunol. 2001 Oct 1; 167(7):4083-90. 1006424
    View PubMed
  27. Gabriel SE, Wagner JL, Zinsmeister AR, Scott CG, Luthra HS. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists? Arthritis Rheum. 2001 Jul; 44(7):1504-14. 1314728
    View PubMed
  28. Khare SD, Lee S, Bull MJ, Hanson J, Luthra HS, David CS. Spontaneous inflammatory disease in HLA-B27 transgenic mice does not require transporter of antigenic peptides. Clin Immunol. 2001 Mar; 98(3):364-9. 1004019
    View PubMed
  29. Wasserman SI, Kimball HR, Duffy FD, and for the Task Force on Recertification. Recertification in internal medicine: a program of continuous professional development. Ann Intern Med. 2000 Aug 1; 133(3):202-8. 2121269
    View PubMed
  30. Lee S, Khare SD, Griffiths MM, Luthra HS, David CS. HLA-B27 transgenic mice are susceptible to collagen-induced arthritis: type II collagen as a potential target in human disease. Hum Immunol. 2000 Feb; 61(2):140-7. 1011667
    View PubMed
  31. Menke DM, Griesser H, Moder KG, Tefferi A, Luthra HS, Cohen MD, Colon-Otero G, Lloyd RV. Lymphomas in patients with connective tissue disease. Comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate. Am J Clin Pathol. 2000 Feb; 113(2):212-8. 127590
    View PubMed
  32. Pan S, Taneja V, Griffiths MM, Luthra H, David CS. Complementation between HLA-DR4 (DRB1*0401) and specific H2-A molecule in transgenic mice leads to collagen-induced arthritis. Hum Immunol. 1999 Sep; 60(9):816-25. 1010017
    View PubMed
  33. Krco CJ, Watanabe S, Harders J, Griffths MM, Luthra H, David CS. Identification of T cell determinants on human type II collagen recognized by HLA-DQ8 and HLA-DQ6 transgenic mice. J Immunol. 1999 Aug 1; 163(3):1661-5. 1010013
    View PubMed
  34. Das P, Bradley DS, Geluk A, Griffiths MM, Luthra HS, David CS. An HLA-DRB1*0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice. Hum Immunol. 1999 Jul; 60(7):575-82. 1009960
    View PubMed
  35. Gabriel SE, Crowson CS, Luthra HS, Wagner JL, O'Fallon WM. Modeling the lifetime costs of rheumatoid arthritis. J Rheumatol. 1999 Jun; 26(6):1269-74. 115960
    View PubMed
  36. Khare SD, Lee S, Bull MJ, Hanson J, Luthra HS, Hammerling GJ, David CS. Peptide binding alpha1alpha2 domain of HLA-B27 contributes to the disease pathogenesis in transgenic mice. Hum Immunol. 1999 Feb; 60(2):116-26. 1008801
    View PubMed
  37. Bradley DS, Das P, Griffiths MM, Luthra HS, David CS. HLA-DQ6/8 double transgenic mice develop auricular chondritis following type II collagen immunization: a model for human relapsing polychondritis. J Immunol. 1998 Nov 1; 161(9):5046-53. 1019957
    View PubMed
  38. Khare SD, Luthra HS, David CS. Animal models of human leukocyte antigen B27-linked arthritides. Rheum Dis Clin North Am. 1998 Nov; 24(4):883-94, xi-xii. 1020369
    View PubMed
  39. Taneja V, Griffiths MM, Luthra H, David CS. Modulation of HLA-DQ-restricted collagen-induced arthritis by HLA-DRB1 polymorphism. Int Immunol. 1998 Oct; 10(10):1449-57. 1314386
    View PubMed
  40. Khare SD, Luthra HS, David CS. Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice. Semin Immunol. 1998 Feb; 10(1):15-23. 1644565
    View PubMed
  41. Khare SD, Bull MJ, Hanson J, Luthra HS, David CS. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides. J Immunol. 1998 Jan 1; 160(1):101-6. 1018566
    View PubMed
  42. Khare SD, Luthra HS, David CS. HLA-B27 and other predisposing factors in spondyloarthrapathies. Curr Opin Rheumatol. 1998; 10(4):282-291. 1020576
    View PubMed
  43. Bradley DS, Nabozny GH, Cheng S, Zhou P, Griffiths MM, Luthra HS, David CS. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J Clin Invest. 1997 Nov 1; 100(9):2227-34. 1017356
    View PubMed
  44. Taneja V, Hansen J, Smart M, Griffiths M, Luthra H, David CS. Expression of the H2-E molecule mediates protection to collagen-induced arthritis in HLA-DQ8 transgenic mice: role of cytokines. Int Immunol. 1997 Aug; 9(8):1213-9. 1016271
    View PubMed
  45. Khare SD, Hansen J, Luthra HS, David CS. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m. J Clin Invest. 1996 Dec 15; 98(12):2746-55. 1027087
    View PubMed
  46. Gonzalez-Gay MA, Zanelli E, Khare SD, Krco CJ, Zhou P, Inoko H, Griffiths MM, Luthra HS, David CS. Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice. Hum Immunol. 1996 Sep 15; 50(1):54-60. 1027085
    View PubMed
  47. Krco CJ, Pawelski J, Harders J, McCormick D, Griffiths M, Luthra HS, David CS. Characterization of the antigenic structure of human type II collagen. J Immunol. 1996 Apr 15; 156(8):2761-8. 1025727
    View PubMed
  48. Nabozny GH, Baisch JM, Cheng S, Cosgrove D, Griffiths MM, Luthra HS, David CS. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med. 1996 Jan 1; 183(1):27-37. 1025865
    View PubMed
  49. Khare SD, Luthra HS, David CS. Role of HLA-B27 in spondyloarthropathies. Curr Top Microbiol Immunol. 1996; 206:85-100. 1026084
    View PubMed
  50. Gonzalezgay MA, Zanelli E, Khare SD, Krco CJ, Griffiths MM, Luthra HS, David CS. Polymorphism contributes to H2-E-beta-mediated protection in collagen-induced arthritis. Immunogenetics. 1996; 44(5):377-384. 1027086
    View PubMed
  51. Khare SD, Krco CJ, Griffiths MM, Luthra HS, David CS. Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J Immunol. 1995 Oct 1; 155(7):3653-9. 1023518
    View PubMed
  52. Khare SD, Luthra HS, David CS. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J Exp Med. 1995 Oct 1; 182(4):1153-8. 1024108
    View PubMed
  53. Moder KG, Gaffey TA, Luthra HS. Musculoskeletal radiology quiz. A smoker with a pulmonary nodule and progressive neurologic deficits. J Musculoskeletal Med. 1995 Oct; 12(10):71-2, 74. 91222
  54. Moder KG, Tefferi A, Cohen MD, Menke DM, Luthra HS. Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. Am J Med. 1995 Sep; 99(3):276-81. 93740
    View PubMed
  55. David CS, Nabozny GH, Gonzalez-Gay M, Zanelli E, Griffiths M, Luthra H. Polymorphism in the HLA-DQ locus determines susceptibility and polymorphism in the HLA-DR beta 1 genes determine protection in collagen induced arthritis: implications in human rheumatoid arthritis. Ann Rheum Dis. 1995 Sep; 54(9):760-761. 1024104
  56. Nabozyny GH, Rimm IJ, Griffiths MM, Luthra HS, David CS. Expression of an ovalbumin-specific V(beta)8.2 TCR transgene inhibits collagen arthritis in B10.Q mice. Int Immunol. 1995 Aug; 7:1279-1286. 1024106
    View PubMed
  57. Nabozny GH, Griffiths MM, Rimm IJ, Luthra HS, David CS. Effect of constrained T-cell receptor repertoires on collagen-induced arthritis in T-cell receptor V beta transgenic and congenic mice. Ann N Y Acad Sci. 1995 Jul 7; (756):217-20. 1023274
  58. Nabozny GH, Hanson J, Griffiths MM, Luthra HS, David CS. Altered development of collagen induced arthritis in T cell receptor V beta congenic B10.RIII mice. Autoimmunity. 1995; 20(1):51-8. 1023351
    View PubMed
  59. Nabozny GH, Griffiths MM, Harper DS, Luthra HS, David CS. Identification of a cyanogen bromide fragment of porcine type II collagen capable of modulating collagen arthritis in B10.RIII (H-2r) mice. Autoimmunity. 1995; 20(1):39-49. 1023402
    View PubMed
  60. Gonzalez-Gay MA, Zanelli E, Krco CJ, Nabozny GH, Hanson J, Griffiths MM, Luthra HS, David CS. Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis. Immunogenetics. 1995; 42(1):35-40. 1022530
    View PubMed
  61. Gonzalez-Gay MA, Nabozny GH, Bull MJ, Zanelli E, Douhan J 3rd, Griffiths MM, Glimcher LH, Luthra HS, David CS. Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis. J Exp Med. 1994 Oct 1; 180(4):1559-64. 1034008
    View PubMed
  62. Griffiths MM, Nabozny GH, Hanson J, Harper DS, McCall S, Moder KG, Cannon GW, Luthra HS, David CS. Collagen-induced arthritis and TCRs in SWR and B10.Q mice expressing an e (alpha) (k) transgene. J Immunol. 1994 Sep 15; 153:2758-2768. 88973
    View PubMed
  63. Nabozny GH, Bull MJ, Hanson J, Griffiths MM, Luthra HS, David CS. Collagen-induced arthritis in T cell receptor V beta congenic B10.Q mice. J Exp Med. 1994 Aug 1; 180(2):517-24. 1032240
    View PubMed
  64. Rhee RY, Gloviczki P, Luthra HS, Stanson AW, Bower TC, Cherry KJ Jr. Iliocaval complication of retroperitoneal fibrosis. Am J Surg. 1994 Aug; 168:179-183. 1034022
    View PubMed
  65. Gonzalez-Gay MA, Luthra HS, David CS. Collagen-induced arthritis: an experimental model for rheumatoid arthritis. [Spanish]. Rev Esp Reumatol. 1994; 21(8):329-333. 1034016
  66. Moder KG, Luthra HS, Griffiths M, David CS. Prevention of collagen induced arthritis in mice by deletion of T cell receptor V beta 8 bearing T cells with monoclonal antibodies. Br J Rheumatol. 1993 Jan; 32(1):26-30. 82907
    View PubMed
  67. Griffiths MM, Cole BC, Ito J, Harper DS, Anderson GD, Cannon GW, Luthra HS, David CS. T-cell receptors and collagen induced arthritis in H-2r mice. Autoimmunity. 1993; 14(3):221-9. 1030367
    View PubMed
  68. Moder KG, Nabozny GH, Luthra HS, David CS. Immunogenetics of collagen induced arthritis in mice: a model for human polyarthritis. Reg Immunol. 1992 Sep-Oct; 4(5):305-13. 81276
    View PubMed
  69. Luthra HS. Newer modalities in the treatment of rheumatoid arthritis. The Practice of Internal Medicine-1992 1992 May 11-15; 319-20. 1027727
  70. Moder KG, Luthra HS, Kubo R, Griffiths M, David CS. Prevention of collagen induced arthritis in mice by treatment with an antibody directed against the T cell receptor alpha beta framework. Autoimmunity. 1992; 11(4):219-24. 82107
    View PubMed
  71. Anderson GD, Banerjee S, Luthra HS, David CS. Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice. J Immunol. 1991 Aug 15; 147(4):1189-93. 78713
    View PubMed
  72. Nickerson C, Luthra H, David C. Antigenic mimicry and autoimmune diseases. Int Rev Immunol. 1991; 7(3):205-24. 78712
    View PubMed
  73. Luthra HS. Rheumatoid arthritis. Clinical Immunology Newsletter. 1990 Sep; 10:127-128. 75370
  74. Luthra HS, David CS. Collagen-induced arthritis in mice: a model for human rheumatoid arthritis? Clinical Immunology Newsletter. 1990 Sep; 10:131-136. 75371
  75. Nickerson CL, Luthra HS, Savarirayan S, David CS. Susceptibility of HLA-B27 transgenic mice to Yersinia enterocolitica infection. Hum Immunol. 1990 Aug; 28(4):382-96. 73091
    View PubMed
  76. Nickerson CL, Luthra HS, David CS. Role of enterobacteria and HLA-B27 in spondyloarthropathies: studies with transgenic mice. Ann Rheum Dis. 1990 Jun; 49(1):426-33. 72766
    View PubMed
  77. Gabriel SE, Conn DL, Luthra H. Rifampin therapy in rheumatoid arthritis. J Rheumatol. 1990 Feb; 17(2):163-6. 72320
    View PubMed
  78. Luthra HS, David CS. Collagen induced arthritis in mice: a model for human rheumatoid arthritis? Clinical Immunology Newsletter. 1990; 10:131-136. 74885
  79. Nickerson CL, Hogen KL, Luthra HS, David CS. Effect of H-2 genes on expression of HLA-B27 and Yersinia-induced arthritis. Scand J Rheumatol Suppl. 1990; 87:85-90, discussion 90. 75176
    View PubMed
  80. Banerjee S, Anderson GD, Luthra HS, David CS. Influence of complement C5 and VB T cell receptor mutations on susceptibility to collagen-induced arthritis in mice. J Immunol. 1989 Apr 1; 142:2237-2243. 68835
    View PubMed
  81. Haqqi TM, Banerjee S, Jones WL, Anderson GD, Behlke MA, Loh DY, Luthra HS, David CS. Identification of T-cell receptor VB deletion mutant mouse strain AU/SSJ (H-2Q) which is resistant to collagen-induced arthritis. Immunogenetics. 1989 Mar; 29:180-185. 68837
    View PubMed
  82. Valente RM, Luthra HS, Robb RA. Quantitative analysis of joint images from patients with rheumatoid arthritis. Proceedings of the IEEE. 1989; 11:1971-1972. 71605
  83. Banerjee S, Luthra HS, Moore SB, O'Fallon WM. Serum IgG anti-native type II collagen antibodies in rheumatoid arthritis: association with HLA DR4 and lack of clinical correlation. Clinical & Experimental Rheumatology. 1988 Oct-Dec; 6(4):373-80. 67105
    View PubMed
  84. Banerjee S, Wei BY, Hillman K, Luthra HS, David CS. Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody. J Immunol. 1988 Aug 15; 141(4):1150-4. 65816
    View PubMed
  85. Valente RM, Luthra HS, Robb RA. Computerized techniques for documenting roentgenograph change (XR) in patients with rheumatoid arthritis (RA). Arthritis Rheum. 1988 Apr; 31(Suppl):S78. 65837
  86. Banerjee S, Haqqi TM, Luthra HS, Stuart JM, David CS. Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J Exp Med. 1988 Mar 1; 167(3):832-9. 65085
    View PubMed
  87. Gabriel SE, Luthra HS. Rheumatoid arthritis: can the long-term outcome be altered? Mayo Clin Proc. 1988 Jan; 63:58-68. 64649
    View PubMed
  88. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31:315-324. 68276
    View PubMed
  89. Lakhanpal S, Ginsburg WW, Luthra HS, Hunder GG. Transient regional osteoporosis. A study of 56 cases and review of the literature. Ann Intern Med. 1987 Mar; 106(3):444-50. 61362
    View PubMed
  90. Michet CJ Jr, Rakela J, Luthra HS. Auranofin-associated colitis and eosinophilia. Mayo Clin Proc. 1987 Feb; 62(2):142-4. 61221
    View PubMed
  91. Luthra HS, Wooley PH, Dillon AM, Singh SK, Lafuse WP, Krco CJ, Huse A, Stuart JM, Griffiths MM, David CS. Immunogenetics of collagen-induced arthritis (CIA) in mice: a model of autoimmune disease. Ann N Y Acad Sci. 1986 Jul 30; 475:361-363. 58949
  92. Hirahara F, Wooley PH, Luthra HS, Coulam CB, Griffiths MM, David CS. Collagen-induced arthritis and pregnancy in mice: the effects of pregnancy on collagen-induced arthritis and the high incidence of infertility in arthritic female mice. American Journal of Reproductive Immunology & Microbiology. 1986 Jun; 11(2):44-54. 58698
    View PubMed
  93. O'Duffy JD, Luthra HS, Unni KK, Hyatt RE. Bronchiolitis in a rheumatoid arthritis patient receiving auranofin. Arthritis Rheum. 1986 Apr; 29(4):556-9. 58471
    View PubMed
  94. Lakhanpal S, McLeod RA, Luthra HS. Insufficiency-type stress fractures in rheumatoid arthritis: report of an interesting case and review of the literature. Clinical & Experimental Rheumatology. 1986 Apr-Jun; 4(2):151-4. 58839
    View PubMed
  95. Dillon AM, Luthra HS, Conn DL, Ferguson RH. Parenteral gold therapy in the Felty syndrome. Experience with 20 patients. Medicine (Baltimore) 1986 Mar; 65(2):107-12. 58107
    View PubMed
  96. Michet CJ Jr, McKenna CH, Luthra HS, O'Fallon WM. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med. 1986 Jan; 104(1):74-8. 60649
    View PubMed
  97. Prakash UB, Luthra HS, Divertie MB. Intrathoracic manifestations in mixed connective tissue disease. Mayo Clin Proc. 1985 Dec; 60(12):813-21. 56074
    View PubMed
  98. del Junco DJ, Annegers JF, Luthra HS, Coulam CB, Kurland LT. Do oral contraceptives prevent rheumatoid arthritis? JAMA. 1985 Oct 11; 254(14):1938-41. 55746
    View PubMed
  99. Wooley PH, Luthra HS, Griffiths MM, Stuart JM, Huse A, David CS. Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule. J Immunol. 1985 Oct; 135(4):2443-51. 55683
    View PubMed
  100. Lakhanpal S, Luthra HS. D-penicillamine in Felty's syndrome. J Rheumatol. 1985 Aug; 12(4):703-6. 55741
    View PubMed
  101. Wooley PH, Luthra HS, Lafuse WP, Huse A, Stuart JM, David CS. Type II collagen-induced arthritis in mice. III. Suppression of arthritis by using monoclonal and polyclonal anti-Ia antisera. J Immunol. 1985 Apr; 134(4):2366-74. 54555
    View PubMed
  102. Hall S, Buettner H, Luthra HS. Occlusive retinal vascular disease in systemic lupus erythematosus. J Rheumatol. 1984 Dec; 11(6):846-50. 52897
    View PubMed
  103. Wooley PH, Luthra HS, Singh SK, Huse AR, Stuart JM, David CS. Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc. 1984 Nov; 59(11):737-43. 52591
    View PubMed
  104. Wooley PH, Luthra HS, Krco CJ, Stuart JM, David CS. Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum. 1984 Sep; 27(9):1010-7. 52359
    View PubMed
  105. Lakhanpal S, Luthra HS. Pleuropulmonary manifestations of rheumatoid disease. Minn Med. 1984 Sep; 67(9):515-6. 53815
    View PubMed
  106. Wooley PH, Luthra HS, O'Duffy JD, Bunch TW, Moore SB, Stuart JM. Anti-type II collagen antibodies in rheumatoid arthritis. The influence of HLA phenotype. Tissue Antigens. 1984 May; 23(5):263-9. 1312884
    View PubMed
  107. del Junco D, Luthra HS, Annegers JF, Worthington JW, Kurland LT. The familial aggregation of rheumatoid arthritis and its relationship to the HLA-DR4 association. Am J Epidemiol. 1984 May; 119(5):813-29. 51639
    View PubMed
  108. O'Duffy JD, Luthra HS. Current status of disease-modifying drugs in progressive rheumatoid arthritis. Drugs. 1984 May; 27(5):373-7. 51618
    View PubMed
  109. Scalapino J, Luthra HS. Raynaud's syndrome. Minn Med. 1984 Apr; 67(4):221-2. 53765
    View PubMed
  110. Hall S, Luthra HS. Rheumatologic manifestations of amyloid disease. Minn Med. 1983 Oct; 66(10):631-2. 49342
    View PubMed
  111. Persellin ST, Griffing WL, Michet CJ, Schroeder KW, Luthra HS. Polymyositis associated with jejunoileal bypass. J Rheumatol. 1983 Aug; 10(4):637-9. 50570
    View PubMed
  112. Wooley PH, Dillon AM, Luthra HS, Stuart JM, David CS. Genetic control of type II collagen-induced arthritis in mice: factors influencing disease susceptibility and evidence for multiple MHC- associated gene control. Transplant Proc. 1983 Mar; 15(BOOK 1):180-185. 48183
  113. Luthra HS, Dillion AM. Gold therapy for Felty's syndrome: current status. Intern Med Spec. 1983; 4:111-122. 50636
  114. Dillon AM, Luthra HS. Lupus nephritis. Minn Med. 1982 Dec; 65(12):737-8. 47618
    View PubMed
  115. Vollertsen RS, Fuster V, Conn DL, Luthra HS, McDuffie FC, Bowie EJ, Ilstrup DM. In vivo platelet survival in rheumatoid arthritis. Mayo Clin Proc. 1982 Oct; 57(10):620-4. 46183
    View PubMed
  116. Jacobs AJ, Luthra HS. Intra-abdominal complications of systemic lupus erythematosus. Minn Med. 1982 Mar; 65(3):183-4. 47619
    View PubMed
  117. Welch CL, Annesley TM, Luthra HS, Moyer TP. Liquid-chromatographic determination of zomepirac in serum and plasma. Clin Chem. 1982 Mar; 28(3):481-4. 47620
    View PubMed
  118. Luthra HS, Conn DL, Ferguson RH. Felty's syndrome: response to parenteral gold. J Rheumatol. 1981 Nov-Dec; 8(6):902-9. 44730
    View PubMed
  119. Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 1981 Sep 1; 154(3):688-700. 44732
    View PubMed
  120. Herberman RB, Bordes M, Lambert PH, Luthra HS, Robins RA, Sizaret P, Theofilopoulos A. Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancer. Int J Cancer. 1981 May 15; 27(5):569-76. 44731
    View PubMed
  121. Luthra HS. Clinical brief: new oral gold compound. Mayo Clin Proc. 1981 Feb; 56:133. 42296
  122. Luthra HS, McKenna CH, Terasaki PI. Lack of association of HLA-A and B locus antigens with relapsing polychondritis. Tissue Antigens. 1981; 17(4):442-3. 44729
    View PubMed
  123. Luthra HS. Ankylosing spondylitis. Minn Med. 1980 Dec; 63(12):885-6. 42096
    View PubMed
  124. Luthra HS. HLA and rheumatic disease. Minn Med. 1980 Sep; 63(9):657-61. 42095
    View PubMed
  125. Griffing WL, Moore SB, Luthra HS, McKenna CH, Fathman CG. Associations of antibodies to native DNA with HLA-DRw3: a possible major histocompatibility complex-linked human immune response gene. J Exp Med. 1980 Aug; 152:319S-325S. 40453
    View PubMed
  126. Sigmond E, Luthra HS. Carpal tunnel syndrome. Minn Med. 1980 Mar; 63(3):213. 42097
    View PubMed
  127. Luthra HS. Extra-articular manifestations of rheumatoid arthritis. Minn Med. 1979 Oct; 62(10):743-4. 38858
    View PubMed
  128. Gupta RC, McDuffie FC, Huston KA, Tappeiner G, Meurer M, Jordon RE, Luthra HS, Hunder GG, Ilstrup D. Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum. 1979 May; 22(5):433-9. 37776
    View PubMed
  129. Luthra HS. Rheumatology corner: examination of the arthritic patient. Minn Med. 1978 Oct; 61:589. 35823
    View PubMed
  130. Luthra H. Aims of diagnosis and management of patients with arthritis. Minn Med. 1978 Jul; 61(7):436. 36641
    View PubMed
  131. Samayoa EA, McDuffie FC, Nelson AM, Go VL, Luthra HS, Brumfield HW. Immunoglobulin complexes in sera of patients with malignancy. Int J Cancer. 1977 Jan; 19(1):12-7. 34421
    View PubMed
  132. McKenna CH, Luthra HS, Jordon RE. Hypocomplementemic ear effusion in relapsing polychondritis. Mayo Clin Proc. 1976 Aug; 51(8):495-7. 31990
    View PubMed
  133. Luthra HS, Ferguson RH, Conn DL. Coexistence of ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 1976 Jan-Feb; 19(1):111-4. 31537
    View PubMed
  134. Luthra HS, Hunder GG. Spontaneous remission of Felty's syndrome. Arthritis Rheum. 1975 Sep-Oct; 18:515-517. 30493
    View PubMed
  135. Luthra HS, McDuffie FC, Hunder GG, Samayoa EA. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest. 1975 Aug; 56:458-466. 30340
    View PubMed